Previous Page  6 / 25 Next Page
Information
Show Menu
Previous Page 6 / 25 Next Page
Page Background

Page 30

conferenceseries

.com

Volume 8

Journal of Clinical Trials

Pharmacy and Pharmacovigilance 2018

July 16-17, 2018

July 16-17, 2018 Sydney, Australia

Joint Event on

Global Pharmacovigilance and

Advanced Pharmacy

Role of pharmacist in correction of inappropriate medication in hospitalized geriatrics

Akhtar Tavana Ghamsari and Mohammad Abbasinazari

Shahid Beheshti University of Medical Sciences, Iran

Statement of the Problem:

Elderly people with frailty and urgent care needs are major users of health and social care services. The

Beers Criteria for the use of Prescription Inappropriate Medication (PIM) in geriatrics are one of the most frequently consulted sources

regarding the safety of prescribing medications for older adults. The present study aims to evaluate the rate of PIM and effect of the

consultation provided by the clinical pharmacist for alteration of prescription errors.

Methodology & Theoretical Orientation:

In all, 240 elderly patients have been evaluated during eight months in the internal and

surgery wards of a Taleghani Hospital in Tehran, Iran. Mean age of evaluated geriatrics was 71.2±7.9. In case of any deviation from the

Beers Criteria, the clinical pharmacist did an intervention by writing progress notes and talking with physicians for modification in

geriatric medication.

Findings:

High prevalence of PIM has been shown by Pethidine, Alprazolam and Metoclopramide respectively. As much as 33.3%

of the elderly patients had at least one PIM. Moreover, 91.5% of consultations provided by clinical pharmacists have been accepted,

resulting in modifications of inappropriate medication. The acceptance for the correction of non-psychotropic medication was better

than the psychotropic kind.

Conclusion:

Clinical pharmacists play an important role in the modification of the pharmacotherapy of hospitalized elderly patients

through consultation with physicians.

akhtar_tavana@yahoo.com

J Clin Trials 2018, Volume 8

DOI: 10.4172/2167-0870-C2-026